BLRX
BioLineRx Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$2.49
−1.70%Institutional positioning
13F filings over the trailing two quarters
New 5Increased 4Reduced 9Sold out 3
| Filer | Action | Shares | Filed |
|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Increased | 69,911 | Aug 14, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | New Position | 15,412 | Aug 13, 2026 |
| CITADEL ADVISORS LLC | New Position | 14,796 | Sep 2, 2026 |
| XTX TOPCO LTD | New Position | 10,941 | May 15, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | New Position | 10,200 | May 15, 2026 |
| RHUMBLINE ADVISERS | Increased | 2,478 | Aug 12, 2026 |
| RHUMBLINE ADVISERS | Reduced | 2,353 | May 12, 2026 |
| WELLS FARGO & COMPANY/MN | Increased | 2,000 | Aug 14, 2026 |
| BNP PARIBAS ARBITRAGE, SNC | Increased | 1,800 | May 12, 2026 |
| WELLS FARGO & COMPANY/MN | Unchanged | 1,750 | Jul 8, 2026 |
| CITIGROUP INC | Reduced | 1,728 | May 11, 2026 |
| UBS GROUP AG | Reduced | 529 | May 5, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | Reduced | 500 | Aug 13, 2026 |
| NEMES RUSH GROUP LLC | Unchanged | 250 | Apr 21, 2026 |
| Nemes Rush Group LLC | Unchanged | 250 | Aug 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings